These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8838145)

  • 1. Identification of a new G-protein-linked receptor for growth hormone secretagogues.
    Pong SS; Chaung LY; Dean DC; Nargund RP; Patchett AA; Smith RG
    Mol Endocrinol; 1996 Jan; 10(1):57-61. PubMed ID: 8838145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubilization and characterization of a growth hormone secretagogue receptor from porcine anterior pituitary membranes.
    Pomés A; Pong SS; Schaeffer JM
    Biochem Biophys Res Commun; 1996 Aug; 225(3):939-45. PubMed ID: 8780714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines.
    Cassoni P; Papotti M; Ghè C; Catapano F; Sapino A; Graziani A; Deghenghi R; Reissmann T; Ghigo E; Muccioli G
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1738-45. PubMed ID: 11297611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels.
    Kineman RD; Kamegai J; Frohman LA
    Endocrinology; 1999 Aug; 140(8):3581-6. PubMed ID: 10433214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ghrelin and growth hormone (GH) secretagogues potentiate GH-releasing hormone (GHRH)-induced cyclic adenosine 3',5'-monophosphate production in cells expressing transfected GHRH and GH secretagogue receptors.
    Cunha SR; Mayo KE
    Endocrinology; 2002 Dec; 143(12):4570-82. PubMed ID: 12446584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland.
    Muccioli G; Ghè C; Ghigo MC; Papotti M; Arvat E; Boghen MF; Nilsson MH; Deghenghi R; Ong H; Ghigo E
    J Endocrinol; 1998 Apr; 157(1):99-106. PubMed ID: 9614363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A receptor in pituitary and hypothalamus that functions in growth hormone release.
    Howard AD; Feighner SD; Cully DF; Arena JP; Liberator PA; Rosenblum CI; Hamelin M; Hreniuk DL; Palyha OC; Anderson J; Paress PS; Diaz C; Chou M; Liu KK; McKee KK; Pong SS; Chaung LY; Elbrecht A; Dashkevicz M; Heavens R; Rigby M; Sirinathsinghji DJ; Dean DC; Melillo DG; Patchett AA; Nargund R; Griffin PR; DeMartino JA; Gupta SK; Schaeffer JM; Smith RG; Van der Ploeg LH
    Science; 1996 Aug; 273(5277):974-7. PubMed ID: 8688086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors.
    McKee KK; Palyha OC; Feighner SD; Hreniuk DL; Tan CP; Phillips MS; Smith RG; Van der Ploeg LH; Howard AD
    Mol Endocrinol; 1997 Apr; 11(4):415-23. PubMed ID: 9092793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone secretagogue binding sites in peripheral human tissues.
    Papotti M; Ghè C; Cassoni P; Catapano F; Deghenghi R; Ghigo E; Muccioli G
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3803-7. PubMed ID: 11061542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortistatin mimics somatostatin by inducing a dual, dose-dependent stimulatory and inhibitory effect on growth hormone secretion in somatotropes.
    Luque RM; Peinado JR; Gracia-Navarro F; Broglio F; Ghigo E; Kineman RD; Malagón MM; Castaño JP
    J Mol Endocrinol; 2006 Jun; 36(3):547-56. PubMed ID: 16720722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the somatostatin receptor subtypes (sst) mediating the divergent, stimulatory/inhibitory actions of somatostatin on growth hormone secretion.
    Luque RM; Durán-Prado M; García-Navarro S; Gracia-Navarro F; Kineman RD; Malagón MM; Castaño JP
    Endocrinology; 2006 Jun; 147(6):2902-8. PubMed ID: 16543371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of pulsatile GH release through a novel receptor in hypothalamus and pituitary gland.
    Smith RG; Pong SS; Hickey G; Jacks T; Cheng K; Leonard R; Cohen CJ; Arena JP; Chang CH; Drisko J; Wyvratt M; Fisher M; Nargund R; Patchett A
    Recent Prog Horm Res; 1996; 51():261-85; discussion 285-6. PubMed ID: 8701083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of 125I-labeled ghrelin to membranes from human hypothalamus and pituitary gland.
    Muccioli G; Papotti M; Locatelli V; Ghigo E; Deghenghi R
    J Endocrinol Invest; 2001 Mar; 24(3):RC7-9. PubMed ID: 11314756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the pituitary-specific transcription factor GHF-1/Pit-1 messenger ribonucleic acid levels by growth hormone-secretagogues in rat anterior pituitary cells in monolayer culture.
    Soto JL; Castrillo JL; Dominguez F; Dieguez C
    Endocrinology; 1995 Sep; 136(9):3863-70. PubMed ID: 7649093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of action of a second generation growth hormone-releasing peptide (Ala-His-D-beta Nal-Ala-Trp-D-Phe-Lys-NH2) in rat anterior pituitary cells.
    Akman MS; Girard M; O'Brien LF; Ho AK; Chik CL
    Endocrinology; 1993 Mar; 132(3):1286-91. PubMed ID: 8095015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacology of human growth hormone and its secretagogues.
    Root AW; Root MJ
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Apr; 2(1):27-52. PubMed ID: 12477295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of the miRNA expression profile in male porcine anterior pituitary cells in response to GHRH and CST and analysis of the potential roles for miRNAs in regulating GH.
    Qi QE; Xi QY; Ye RS; Chen T; Cheng X; Li CY; Zhu XT; Shu G; Wang LN; Jiang QY; Zhang YL
    Growth Horm IGF Res; 2015 Apr; 25(2):66-74. PubMed ID: 25613666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic targets for growth hormone secretagogues.
    Robinson IC
    Acta Paediatr Suppl; 1997 Nov; 423():88-91. PubMed ID: 9401551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of growth hormone secretagogues.
    Smith RG
    Endocr Rev; 2005 May; 26(3):346-60. PubMed ID: 15814848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells.
    Ghè C; Cassoni P; Catapano F; Marrocco T; Deghenghi R; Ghigo E; Muccioli G; Papotti M
    Endocrinology; 2002 Feb; 143(2):484-91. PubMed ID: 11796502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.